Share 'Pfizer Extends Age Eligibility for Myostatin Inhibitor Trial'
I haven't seen this on PPMD yet so I thought I'd share.
Pfizer has extended the age range for their Myostatin Inhibitor trial. Originally it was, if I remember correctly, 6<10 years of age. They have extended that to 6<16. As far as I can tell, the other criteria has remained the same.
This is good news for our family. Our oldest was tested, about a week before his tenth birthday, and w…
You can share this discussion in two ways…
Share this link:
Send it with your computer's email program: Email this